Favorable regulatory environment coupled with in-depth local knowledge of submission guidelines and algorithms assures that, depending on the country, your study will be up and running within 8-20 weeks (from the moment of documents receipt from the client).
Active patient recruitment and retention
By analyzing study population, sites’ motivation to enroll, type of disease, subjects’ barriers to participate in studies, we developed an active approach to resolving any the issues related to subject recruitment and retention. Read more…
"No Patients - No Payments"
Rapid enrollment is supported by “No patients – no payments” initiative which assures that client reimburses Cromos Pharma only for enrolled patients and not for dormant, non-recruiting sites
Our experienced feasibility team will swiftly prepare a detailed capability/feasibility report and will suggest the best path forward, including country- and site-selection
Quality Management (Quality by Design – QBD)
We adhere to Quality by Design principles that include integrated planning, real-time project risk-based analysis and customer-focused optimization
Welfare of our patients is our first priority. We are fully compliant with ICH-GCP and make sure that patients in our studies are well-informed, and have a direct line of communication to both the investigators and to our research team
CPR: Capability → Plan → Rescue
If your study is behind schedule or encounters difficulties with recruitment or retention of subjects, Cromos Pharma can provide comprehensive rescue plans to ensure original investments yield a return and that studies are efficiently concluded. We offer the most rational and economic rescue plans to sponsor companies to ensure value for money at every stage of the service